HAS2 and Hyperglycemia: Hyaluronan (HA), a key element of the ECM, was incrementally secreted under hyperglycemia, and inhibition of PKC-β reduced the expression of HAS2 (hyaluronan synthase 2) mRNA and secretion of HA (52).